Business

Catalent and Novo Holdings receive European Commission unconditional approval for pending transaction

Transaction expected to close towards the end of calendar year 2024   SOMERSET, N.J. & COPENHAGEN, Denmark — (BUSINESS WIRE) — Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo

Business

inTEST Corporation to participate in the 13th Annual NYC Summit

MT. LAUREL, N.J. — (BUSINESS WIRE) — inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor